Waste Management
Compare Stocks
5 / 10Stock Comparison
LNZA vs OPAL vs CLNE vs GEVO vs AMTX
Revenue, margins, valuation, and 5-year total return — side by side.
Regulated Gas
Oil & Gas Refining & Marketing
Chemicals - Specialty
Oil & Gas Refining & Marketing
LNZA vs OPAL vs CLNE vs GEVO vs AMTX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Waste Management | Regulated Gas | Oil & Gas Refining & Marketing | Chemicals - Specialty | Oil & Gas Refining & Marketing |
| Market Cap | $53M | $54M | $507M | $493M | $213M |
| Revenue (TTM) | $40M | $349M | $439M | $174M | $209M |
| Net Income (TTM) | $-76M | $15M | $-99M | $-11M | $-74M |
| Gross Margin | 29.0% | 28.1% | 11.7% | 23.4% | 3.4% |
| Operating Margin | -265.8% | 1.4% | 7.4% | -4.6% | -13.4% |
| Forward P/E | — | 15.6x | — | — | — |
| Total Debt | $82M | $365M | $99M | $168M | $318M |
| Cash & Equiv. | $43M | $24M | $158M | $1M | $5M |
LNZA vs OPAL vs CLNE vs GEVO vs AMTX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| LanzaTech Global, I… (LNZA) | 100 | 2.3 | -97.7% |
| OPAL Fuels Inc. (OPAL) | 100 | 22.1 | -77.9% |
| Clean Energy Fuels … (CLNE) | 100 | 28.3 | -71.7% |
| Gevo, Inc. (GEVO) | 100 | 28.8 | -71.2% |
| Aemetis, Inc. (AMTX) | 100 | 17.2 | -82.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LNZA vs OPAL vs CLNE vs GEVO vs AMTX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LNZA is the clearest fit if your priority is income & stability.
- Dividend streak 1 yrs, beta 1.64
OPAL carries the broadest edge in this set and is the clearest fit for quality and dividends.
- 4.2% margin vs LNZA's -190.2%
- 15.3% yield; the other 4 pay no meaningful dividend
- 1.6% ROA vs LNZA's -58.8%, ROIC 0.5% vs -147.7%
CLNE is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- -26.9% 10Y total return vs AMTX's 31.1%
- Lower volatility, beta 1.19, Low D/E 17.5%, current ratio 2.32x
- Beta 1.19, current ratio 2.32x
- Beta 1.19 vs LNZA's 1.64, lower leverage
GEVO ranks third and is worth considering specifically for growth exposure.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- 8.5% revenue growth vs AMTX's -22.3%
AMTX is the clearest fit if your priority is momentum.
- +140.0% vs LNZA's -5.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs AMTX's -22.3% | |
| Quality / Margins | 4.2% margin vs LNZA's -190.2% | |
| Stability / Safety | Beta 1.19 vs LNZA's 1.64, lower leverage | |
| Dividends | 15.3% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +140.0% vs LNZA's -5.2% | |
| Efficiency (ROA) | 1.6% ROA vs LNZA's -58.8%, ROIC 0.5% vs -147.7% |
LNZA vs OPAL vs CLNE vs GEVO vs AMTX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
LNZA vs OPAL vs CLNE vs GEVO vs AMTX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
OPAL leads in 2 of 6 categories
LNZA leads 1 • CLNE leads 0 • GEVO leads 0 • AMTX leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — OPAL and CLNE each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CLNE is the larger business by revenue, generating $439M annually — 11.0x LNZA's $40M. OPAL is the more profitable business, keeping 4.2% of every revenue dollar as net income compared to LNZA's -190.2%. On growth, GEVO holds the edge at +47.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $40M | $349M | $439M | $174M | $209M |
| EBITDAEarnings before interest/tax | -$102M | $28M | $62M | $18M | -$21M |
| Net IncomeAfter-tax profit | -$76M | $15M | -$99M | -$11M | -$74M |
| Free Cash FlowCash after capex | -$81M | -$34M | $19M | -$35M | -$38M |
| Gross MarginGross profit ÷ Revenue | +29.0% | +28.1% | +11.7% | +23.4% | +3.4% |
| Operating MarginEBIT ÷ Revenue | -2.7% | +1.4% | +7.4% | -4.6% | -13.4% |
| Net MarginNet income ÷ Revenue | -190.2% | +4.2% | -22.7% | -6.6% | -35.4% |
| FCF MarginFCF ÷ Revenue | -2.0% | -9.8% | +4.3% | -19.9% | -18.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -6.7% | +24.7% | +13.3% | +47.5% | +27.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +103.4% | +2.7% | +90.0% | +3.8% | +29.8% |
Valuation Metrics
OPAL leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, OPAL's 14.0x EV/EBITDA is more attractive than GEVO's 102.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $53M | $54M | $507M | $493M | $213M |
| Enterprise ValueMkt cap + debt − cash | $91M | $395M | $448M | $659M | $526M |
| Trailing P/EPrice ÷ TTM EPS | -0.32x | 15.60x | -2.29x | -14.50x | -2.44x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 14.03x | 94.64x | 102.12x | — |
| Price / SalesMarket cap ÷ Revenue | 1.06x | 0.15x | 1.19x | 3.07x | 1.02x |
| Price / BookPrice ÷ Book value/share | 3.33x | 0.14x | 0.90x | 1.01x | — |
| Price / FCFMarket cap ÷ FCF | — | — | 8.47x | — | — |
Profitability & Efficiency
OPAL leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
OPAL delivers a 3.1% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-2 for LNZA. CLNE carries lower financial leverage with a 0.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to LNZA's 6.09x. On the Piotroski fundamental quality scale (0–9), OPAL scores 5/9 vs LNZA's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.2% | +3.1% | -17.2% | -2.4% | — |
| ROA (TTM)Return on assets | -58.8% | +1.6% | -9.2% | -1.7% | -29.3% |
| ROICReturn on invested capital | -147.7% | +0.5% | -9.4% | -2.8% | -70.3% |
| ROCEReturn on capital employed | -60.8% | +0.6% | -9.4% | -3.1% | -19.0% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 5 | 4 | 4 |
| Debt / EquityFinancial leverage | 6.09x | 0.73x | 0.18x | 0.36x | — |
| Net DebtTotal debt minus cash | $38M | $341M | -$59M | $166M | $313M |
| Cash & Equiv.Liquid assets | $43M | $24M | $158M | $1M | $5M |
| Total DebtShort + long-term debt | $82M | $365M | $99M | $168M | $318M |
| Interest CoverageEBIT ÷ Interest expense | — | 0.18x | -1.07x | -0.04x | -0.27x |
Total Returns (Dividends Reinvested)
Evenly matched — GEVO and AMTX each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GEVO five years ago would be worth $3,476 today (with dividends reinvested), compared to $229 for LNZA. Over the past 12 months, AMTX leads with a +140.0% total return vs LNZA's -5.2%. The 3-year compound annual growth rate (CAGR) favors GEVO at 18.2% vs LNZA's -59.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +61.8% | -1.7% | +6.9% | -1.5% | +96.2% |
| 1-Year ReturnPast 12 months | -5.2% | -0.4% | +44.4% | +88.0% | +140.0% |
| 3-Year ReturnCumulative with dividends | -93.4% | -64.5% | -46.3% | +65.0% | +37.4% |
| 5-Year ReturnCumulative with dividends | -97.7% | -76.1% | -73.8% | -65.2% | -76.1% |
| 10-Year ReturnCumulative with dividends | -97.7% | -76.1% | -26.9% | -98.6% | +31.1% |
| CAGR (3Y)Annualised 3-year return | -59.7% | -29.2% | -18.7% | +18.2% | +11.2% |
Risk & Volatility
Evenly matched — CLNE and AMTX each lead in 1 of 2 comparable metrics.
Risk & Volatility
CLNE is the less volatile stock with a 1.19 beta — it tends to amplify market swings less than LNZA's 1.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMTX currently trades 82.1% from its 52-week high vs LNZA's 31.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.65x | 1.56x | 1.19x | 1.64x | 1.27x |
| 52-Week HighHighest price in past year | $71.19 | $4.08 | $3.11 | $2.97 | $3.80 |
| 52-Week LowLowest price in past year | $7.88 | $1.65 | $1.56 | $1.01 | $1.22 |
| % of 52W HighCurrent price vs 52-week peak | +31.8% | +57.4% | +74.3% | +68.4% | +82.1% |
| RSI (14)Momentum oscillator 0–100 | 46.1 | 48.0 | 44.6 | 53.5 | 58.2 |
| Avg Volume (50D)Average daily shares traded | 49K | 198K | 1.3M | 4.5M | 1.8M |
Analyst Outlook
LNZA leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: LNZA as "Hold", CLNE as "Buy", GEVO as "Buy", AMTX as "Buy". Consensus price targets imply 72.4% upside for GEVO (target: $4) vs -75.7% for LNZA (target: $6). OPAL is the only dividend payer here at 15.29% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $5.50 | — | $3.50 | $3.50 | $1.75 |
| # AnalystsCovering analysts | 4 | — | 22 | 14 | 7 |
| Dividend YieldAnnual dividend ÷ price | — | +15.3% | — | — | — |
| Dividend StreakConsecutive years of raises | 1 | 0 | — | — | — |
| Dividend / ShareAnnual DPS | — | $0.36 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% | +1.6% | 0.0% | 0.0% |
OPAL leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). LNZA leads in 1 (Analyst Outlook). 3 tied.
LNZA vs OPAL vs CLNE vs GEVO vs AMTX: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is LNZA or OPAL or CLNE or GEVO or AMTX a better buy right now?
For growth investors, Gevo, Inc.
(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus -22. 3% for Aemetis, Inc. (AMTX). OPAL Fuels Inc. (OPAL) offers the better valuation at 15. 6x trailing P/E, making it the more compelling value choice. Analysts rate Clean Energy Fuels Corp. (CLNE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — LNZA or OPAL or CLNE or GEVO or AMTX?
Over the past 5 years, Gevo, Inc.
(GEVO) delivered a total return of -65. 2%, compared to -97. 7% for LanzaTech Global, Inc. (LNZA). Over 10 years, the gap is even starker: AMTX returned +8. 8% versus GEVO's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — LNZA or OPAL or CLNE or GEVO or AMTX?
By beta (market sensitivity over 5 years), Clean Energy Fuels Corp.
(CLNE) is the lower-risk stock at 1. 19β versus LanzaTech Global, Inc. 's 1. 65β — meaning LNZA is approximately 38% more volatile than CLNE relative to the S&P 500. On balance sheet safety, Clean Energy Fuels Corp. (CLNE) carries a lower debt/equity ratio of 18% versus 6% for LanzaTech Global, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — LNZA or OPAL or CLNE or GEVO or AMTX?
By revenue growth (latest reported year), Gevo, Inc.
(GEVO) is pulling ahead at 849. 3% versus -22. 3% for Aemetis, Inc. (AMTX). On earnings-per-share growth, the picture is similar: OPAL Fuels Inc. grew EPS 638. 9% year-over-year, compared to -173. 0% for Clean Energy Fuels Corp.. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — LNZA or OPAL or CLNE or GEVO or AMTX?
OPAL Fuels Inc.
(OPAL) is the more profitable company, earning 1. 2% net margin versus -277. 7% for LanzaTech Global, Inc. — meaning it keeps 1. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OPAL leads at 1. 4% versus -219. 7% for LNZA. At the gross margin level — before operating expenses — LNZA leads at 47. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — LNZA or OPAL or CLNE or GEVO or AMTX?
In this comparison, OPAL (15.
3% yield) pays a dividend. LNZA, CLNE, GEVO, AMTX do not pay a meaningful dividend and should not be held primarily for income.
07Is LNZA or OPAL or CLNE or GEVO or AMTX better for a retirement portfolio?
For long-horizon retirement investors, OPAL Fuels Inc.
(OPAL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (15. 3% yield). Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (OPAL: -76. 8%, GEVO: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between LNZA and OPAL and CLNE and GEVO and AMTX?
These companies operate in different sectors (LNZA (Industrials) and OPAL (Utilities) and CLNE (Energy) and GEVO (Basic Materials) and AMTX (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: LNZA is a small-cap quality compounder stock; OPAL is a small-cap high-growth stock; CLNE is a small-cap quality compounder stock; GEVO is a small-cap high-growth stock; AMTX is a small-cap quality compounder stock. OPAL pays a dividend while LNZA, CLNE, GEVO, AMTX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.